Clinical Trial Update: Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial (JCOG9502) assessing surgical approaches for gastric cancer invading the esophagus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Gastric Neoplasm | Phase 3 | Status: TERMINATED